• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natural Capsules Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4124.0
  • ISIN : INE936B01015
169.00 2 (1.10%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    163.50

  • Today’s High

    172.35

  • Open

    167.00

  • Perv Close

    167.16

  • 52W Low

    136.36

  • 52W High

    296.00

Key Indicators

  • P/E(TTM)

    14.14

  • Mar.Cap (₹Cr.)

    175.95

  • Div & Yield %

    0.00

  • Book Value(₹)

    172.64

  • Debt-Equity Ratio

    1.10

  • AGM Date

    22-Sep-2026

  • EPS

    12.22

  • P/E Ratio

    14.14

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    175.95

  • RONW (%)

    3.39

  • ROCE (%)

    5.00

Score Board

  • Equity (₹ in Cr.)

    10.41

  • BV (₹)

    172.60

  • Sales( ₹ in Cr.)

    173.77

  • NP (in Cr.)

    11.21

  • NP Var(%)

    67.0

  • Div%

    0.0

  • CPS (₹)

    18.60

  • EPS (₹)

    10.80

  • Traded Value (₹ in Lakhs)

    179.96

  • 52 Week High

    296.00

  • 52 Week Low

    136.36

  • Price BSE

    173.0

  • Price NSE

    169.00

  • Market Capital( in Cr.)

    179.96

  • P/C Ratio

    9.30

  • P/E Ratio

    16.10

  • Price Vs.BV

    10.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 173.77 167.94 153.81 172.87 135.07 79.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 173.77 167.94 153.81 172.87 135.07 79.51
Other Income 7.65 4.24 3.15 1.07 0.93 2.90
Stock Adjustments 0.21 1.13 6.13 5.18 -1.81 -1.33
Total Income 181.63 173.31 163.09 179.12 134.19 81.08
EXPENDITURE :            
Raw Materials 87.42 85.12 83.32 84.14 57.99 36.10
Power and Fuel Cost 16.53 15.83 15.19 13.75 11.90 8.51
Employee Cost 13.75 12.29 10.95 9.51 8.48 6.97
Other Manufacturing Expenses 14.69 13.48 12.58 11.79 7.57 4.45
Selling and Administration Expenses 20.85 21.81 17.70 22.86 16.87 9.73
Miscellaneous Expenses -1.06 1.06 -0.70 0.24 4.83 1.29
Employee Benefit Expenses 13.75 12.29 10.95 9.51 8.48 6.97
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 152.18 149.59 139.04 142.30 107.64 67.05
Operating Profit 29.46 23.72 24.05 36.82 26.54 14.04
Interest 6.23 6.09 5.09 3.88 2.08 0.54
Gross Profit 23.23 17.63 18.96 32.94 24.46 13.50
Depreciation 8.16 8.33 8.57 7.20 5.04 4.31
Profit Before Tax 15.07 9.30 10.39 25.74 19.42 9.19
Current Tax 3.62 1.23 1.97 5.46 4.74 2.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.23 1.36 0.62 1.09 0.73 0.02
Reported Net Profit 11.21 6.71 7.81 19.20 13.95 6.95
Extraordinary Items 0.00 0.00 0.00 0.03 0.05 1.65
Adjusted Net Profit 11.21 6.71 7.81 19.17 13.90 5.30
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.20 -0.06
P & L Balance brought forward 87.87 81.16 74.29 55.86 42.73 36.22
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.93 0.77 0.62 0.37
P & L Balance carried down 99.09 87.87 81.16 74.29 55.86 42.73
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 10.00 10.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.00 1.00 1.00
Earnings Per Share-Unit Curr 10.80 6.49 8.36 20.70 19.90 11.15
Earnings Per Share(Adj)-Unit Curr 10.80 6.49 8.36 20.70 19.90 9.14
Book Value 173.03 160.83 141.30 133.74 118.45 99.68
Book Value(Adj)-Unit Curr 173.03 160.83 141.30 133.74 118.45 81.74

Shareholding Pattern

  • Promoter Group

    50.92%

  • Public Share Holding

    49.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,172,854 20.87 2,172,854 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 2,261 0.02 2,261 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,126,133 30.03 3,126,133 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,301,248 50.92 5,301,248 19
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 995,113 9.56 993,713 66
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 188,176 1.81 185,076 129
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 307,606 2.95 307,606 188
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,074,258 10.32 1,074,258 17
Individuals holding nominal share capital up to Rs. 1 lakh 2,385,402 22.91 2,299,977 8,332
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 136,131 1.31 136,131 1
Sub Total 5,109,906 49.08 5,019,981 8,737
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,411,154 100.00 10,321,229 8,756

Company Background

Natural Capsules LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natural Capsules Ltd
  • BSE Code : 4124.0
  • ISIN : INE936B01015

  • Incorporation Year

    1993

  • Registered Office

    Trident Towers 4th Floor No 23
    100Feet Road Jayanagar IIBlock, Bangalore,
    Karnataka-560011

  • Telephone

    91-080-26671571/26671573/26671581

  • FAX

    91-080-26671562

  • Chairman

    T Y Prabhu

  • Managing Director

  • Company Secretary

    Akshay Dutta

  • Auditor

    P Chandrasekar LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Natural Capsules Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natural Capsules 172.85 181.42 173.77 14.14 9.19
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77